Prevalence of pain in patients with cancer: a systematic review of the past 40 years.
By M. V. D. B. Everdingen, J. M. Rijke, A. Kessels, H. Schouten, M. Kleef, J. Patijn. Annals of Oncology, 2007
1,853 citations recorded by the source corpus.
Subfields: Anesthesiology and Pain Medicine, Oncology, Pulmonary and Respiratory Medicine
View Paper: https://www.semanticscholar.org/paper/6c86b08ad1d7736eddbbb98e0c79200f8f6e0a0a
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Anesthesiology and Pain Medicine
In Oncology
In Pulmonary and Respiratory Medicine
Citations in the corpus
- Cancer treatment and survivorship statistics, 2012 (2012, background): “Although studies suggest that pain control can be achieved for 80% of cancer patients experiencing pain, it is frequently underassessed, underreported, and undertreated.(126) Both surgery and radiation therapy can cause nerve damage, resulting in chronic pain.”
- The individual and societal burden of chronic pain in Europe: the case for strategic prioritisation and action to improve knowledge and availability of appropriate care (2013, background): “Half of all cancer patients, and up to 80% of those at advanced or terminal stages, experience chronic pain [13,21-24].”
- Update on Prevalence of Pain in Patients With Cancer: Systematic Review and Meta-Analysis. (2016, methodology): “In 2007, a systematic review was published on the p revalence of cancer pain over a time perspective of 40 years (7).”
- Prevalence of undertreatment in cancer pain. A review of published literature. (2008, background): “Pain is a major health care problem for patients with cancer [1]: a recent meta-analysis reports that 64% of patients with advanced stage disease or metastatic cancer will experience pain [2].”
- A classification of chronic pain for ICD-11 (2015, background): “makes the acquisition of accurate epidemiological d ata related to chronic pain difficult, prevents adequate billing for healthcare expenses r elated to pain treatment, and hinders the development and implementation of new therapies [11 ,12, 7,23,27,31,37].”